Dose response effect of methylphenidate on ventral tegmental area neurons and animal behavior

Brain Research Bulletin

Volumn 96, Issue , 2013, Pages 86-92

  Jones, Zachary ^a   Dafny, Nachum ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Locomotion; Neuronal activity; Psychostimulant; Ritalin; VTA

Indexed keywords

METHYLPHENIDATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TELEMETRY; VENTRAL TEGMENTUM;

LOCOMOTION; NEURONAL ACTIVITY; PSYCHOSTIMULANT; RITALIN; VTA;

ANIMALS; BEHAVIOR, ANIMAL; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 84878796007     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.03.004     Document Type: Article

References (65)

1. Alcaro A., Huber R., Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Research Reviews 2007, 56:283-321.
2. Algahim M.F., Yang P.B., Wilcox V.T., Burau K.D., Swann A.C., Dafny N. Prolonged methylphenidate treatment alters the behavioral diurnal activity pattern of adult male Sprague-Dawley rats. Pharmacology Biochemistry and Behavior 2009, 92:93-99.
3. Calipari E.S., Ferris M.J., Melchior J.R., Bermejo K., Salahpour A., Roberts D.C., Jones S.R. Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations. Addiction Biology 2012, 10.1111/j.1369-1600.2012.00456.x.
4. Casada J.H., Dafny N. Evidence for two different afferent pathways carrying stress-related information (noxious and amygdala stimulation) to the bed nucleus of the stria terminalis. Brain Research 1992, 579:93-98.
5. Challman T.D., Lipsky J.J. Methylphenidate: its pharmacology and uses. Mayo Clinic Proceedings 2000, 75:711-721.
6. Chong S., Claussen C., Dafny N. Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration. Brain Research Bulletin 2012, 87:445-456.
7. Claussen C.M., Dafny N. Acute and chronic methylphenidate modulates the neuronal activity of the caudate nucleus recorded from freely behaving rats. Brain Research Bulletin 2012, 87:387-396.
8. Crutchley A., Temlett J.A. Methylphenidate (Ritalin) use and abuse. South African Medical Journal 1999, 89:1076-1079.
9. Dafny N. Electrophysiological properties of caudate neurons following substantia nigra, motor cortex, and amygdaloid nuclear complex stimulation of the rat. Applied Neurophysiology 1975, 38:259-272.
10. Dafny N. Multiunit recording from medial basal hypothalamus following acute and chronic morphine treatment. Brain Research 1980, 190:584-592.
11. Dafny N. The hypothalamus exhibits electrophysiologic evidence for morphine tolerance and dependence. Experimental Neurology 1982, 77:66-77.
12. Dafny N., Yang P.B. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Research Bulletin 2006, 68:393-405.
13. Eichlseder W. Ten years of experience with 1,000 hyperactive children in a private practice. Pediatrics 1985, 76:176-184.
14. Fan D., Rich D., Holtzman T., Ruther P., Dalley J.W., Lopez A., Rossi M.A., Barter J.W., Salas-Meza D., Herwik S., Holzhammer T., Morizio J., Yin H.H. A wireless multi-channel recording system for freely behaving mice and rats. PLoS ONE 2011, 6:e22033.
15. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114(Pt 5):2283-2301.
16. Gatley S.J., Volkow N.D., Gifford A.N., Fowler J.S., Dewey S.L., Ding Y.S., Logan J. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology 1999, 146:93-100.
17. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Research 1996, 727:13-21.
18. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Research 1997, 777:1-12.
19. Gaytan O., Yang P., Swann A., Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Research 2000, 864:24-39.
20. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., Molina P.E., Dewey S.L. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. Journal of Pharmacology and Experimental Therapeutics 2000, 295:51-57.
21. Grace A.A., Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. Journal of Neuroscience 1989, 9:3463-3481.
22. Gronier B. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors. European Neuropsychopharmacology 2011, 21:192-204.
23. Harvey R.C., Sen S., Deaciuc A., Dwoskin L.P., Kantak K.M. Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function. Neuropsychopharmacology 2011, 36:837-847.
24. Izenwasser S., Coy A.E., Ladenheim B., Loeloff R.J., Cadet J.L., French D. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. European Journal of Pharmacology 1999, 373:187-193.
25. Kallman W.M., Isaac W. The effects of age and illumination on the dose-response curves for three stimulants. Psychopharmacologia 1975, 40:313-318.
26. Kauer J.A. Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annual Review of Physiology 2004, 66:447-475.
27. Kollins S.H. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Journal of Clinical Psychiatry 2003, 64(Suppl. 11):14-18.
28. Lee M.J., Yang P.B., Wilcox V.T., Burau K.D., Swann A.C., Dafny N. Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats?. Neuropharmacology 2009, 57:201-207.
29. Lee R.S., Steffensen S.C., Henriksen S.J. Discharge profiles of ventral tegmental area GABA neurons during movement, anesthesia, and the sleep-wake cycle. Journal of Neuroscience 2001, 21:1757-1766.
30. Liu C.L., Gao M., Jin G.Z., Zhen X. GABA neurons in the ventral tegmental area responding to peripheral sensory input. PLoS ONE 2012, 7:e51507.
31. Monti J.M., Fernandez M., Jantos H. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats. Neuropsychopharmacology 1990, 3:153-162.
32. Mueller A.L., Brodie M.S. Intracellular recording from putative dopamine-containing neurons in the ventral tegmental area of Tsai in a brain slice preparation. Journal of Neuroscience Methods 1989, 28:15-22.
33. Nair-Roberts R.G., Chatelain-Badie S.D., Benson E., White-Cooper H., Bolam J.P., Ungless M.A. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 2008, 152:1024-1031.
34. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006, 59:1151-1159.
35. Newcorn J.H. A glimpse into key issues in ADHD. CNS Spectrums 2000, 5:25.
36. Niehaus J.L., Cruz-Bermudez N.D., Kauer J.A. Plasticity of addiction: a mesolimbic dopamine short-circuit?. American Journal on Addictions 2009, 18:259-271.
37. Nishino S., Mao J., Sampathkumaran R., Shelton J. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Research Online 1998, 1:49-61.
38. Olson V.G., Nestler E.J. Topographical organization of GABAergic neurons within the ventral tegmental area of the rat. Synapse 2007, 61:87-95.
39. Parran T.V., Jasinski D.R. Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Archives of Internal Medicine 1991, 151:781-783.
40. Patrick K.S., Markowitz J.S. Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder. Human Psychopharmacology: Clinical and Experimental. 1997, 12:246-527.
41. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986.
42. Perugini M., Vezina P. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. Journal of Pharmacology and Experimental Therapeutics 1994, 270:690-696.
43. Podet A., Lee M.J., Swann A.C., Dafny N. Nucleus accumbens lesions modulate the effects of methylphenidate. Brain Research Bulletin 2010, 82:293-301.
44. Prieto-Gomez B., Benitez M.T., Vazquez-Alvarez A.M., Yang P.B., Reyes V.C., Dafny N. Dopaminergic ventral tegmental neurons modulated by methylphenidate. Life Sciences 2004, 74:1581-1592.
45. Prieto-Gomez B., Vazquez-Alvarez A.M., Martinez-Pena J.L., Reyes-Vazquez C., Yang P.B., Dafny N. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area. Life Sciences 2005, 77:635-649.
46. Rahman S., McBride W.J. D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA). Journal of Neurochemistry 2001, 77:1248-1255.
47. Ranaldi R., Wise R.A. Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. Journal of Neuroscience 2001, 21:5841-5846.
48. Robinson T.E., Berridge K.C. Review. The incentive sensitization theory of addiction: some current issues. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2008, 363:3137-3146.
49. Salek R.L., Claussen C.M., Perez A., Dafny N. Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats. European Journal of Pharmacology 2012, 679:60-67.
50. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. Journal of Pharmacology and Experimental Therapeutics 1995, 273:808-815.
51. Slezak J.M., Anderson K.G. Effects of acute and chronic methylphenidate on delay discounting. Pharmacology Biochemistry and Behavior 2011, 99:545-551.
52. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavioural Brain Research 1998, 94:127-152.
53. Swanson J.M., Cantwell D., Lerner M., McBurnett K., Hanna G. Effects of stimulant medication on learning in children with ADHD. Journal of Learning Disabilities 1991, 24:219-230. 255.
54. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Research 1993, 605:332-337.
55. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., Ashby C., Liebermann J., Hitzemann R. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry 1995, 52:456-463.
56. Volkow N.D., Wang G.J., Tomasi D., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F.W., Fowler J.S., Logan J., Wong C.T., Swanson J.M. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. Journal of Neuroscience 2012, 32:841-849.
57. Wanchoo S.J., Swann A.C., Dafny N. Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate. Brain Research 2009, 1301:68-79.
58. White S.R., Yadao C.M. Characterization of methylphenidate exposures reported to a regional poison control center. Archives of Pediatrics and Adolescent Medicine 2000, 154:1199-1203.
59. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. Journal of Neuroscience 2001, 21:1787-1794.
60. Yang P.B., Amini B., Swann A.C., Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Research 2003, 971:139-152.
61. Yang P.B., Swann A.C., Dafny N. Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Research 2006, 1073-1074:164-174.
62. Yang P.B., Swann A.C., Dafny N. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats. Neuropharmacology 2006, 51:546-556.
63. Yang P.B., Swann A.C., Dafny N. Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats. Behavioral and Brain Functions 2006, 2:3.
64. Yang P.B., Swann A.C., Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Research Bulletin 2006, 71:301-310.
65. Yang P.B., Swann A.C., Dafny N. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Research 2007, 1145:66-80.